List of SBIR/STTR awards granted to COLUMBUS NANOWORKS, INC.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to COLUMBUS NANOWORKS, INC. in May, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41GM126603-01 | Phase I | 225,000 | May 1, 2018 | |||||||
A SBIR Phase II contract was awarded to COLUMBUS NANOWORKS, INC. in June, 2022 for $1,250,000.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-22-P-0837 | Phase II | 1,250,000 | June 7, 2022 | |||||||
A SBIR Phase I contract was awarded to COLUMBUS NANOWORKS, INC. for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N91019C00014 | Phase I | 299,999 | ||||||||
A SBIR Phase II contract was awarded to COLUMBUS NANOWORKS, INC. for $1,499,656.0 USD from the U.S. Department of Health & Human Services. | SBIR | 268201500011C-0-0-0 | Phase II | 1,499,656 | ||||||||
A SBIR Phase I contract was awarded to COLUMBUS NANOWORKS, INC. for $170,699.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43HL130031 | Phase I | 170,699 | ||||||||
A SBIR Phase II contract was awarded to COLUMBUS NANOWORKS, INC. for $1,024,656.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R42CA116048-02 | Phase II | 1,024,656 | ||||||||
A STTR Phase II contract was awarded to COLUMBUS NANOWORKS, INC. for $167,039.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42CA116048-02 | Phase II | 167,039 | ||||||||
A SBIR Phase I contract was awarded to COLUMBUS NANOWORKS, INC. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA116048-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to COLUMBUS NANOWORKS, INC. for $354,994.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N91023C00006 | Phase I | 354,994 |
